Coronavirus: Johnson & Johnson Covid-19 vaccine won’t be supplied to Hong Kong this year, source says, dashing experts’ hopes of replacement for AstraZeneca shots

Apr 10, 2021 | INVESTING

US drug giant Johnson & Johnson, whose Covid-19 vaccine has been touted by some local health experts as a promising replacement for the AstraZeneca jab, has no plans to supply Hong Kong this year, the Post has learned.While officials are pinning their hopes on second-generation jabs to counter new coronavirus variants, top public health experts such as Professor Gabriel Leung, dean of the University of Hong Kong’s faculty of medicine, believe the government also needs to come up with more…

Read More

Pin It on Pinterest